HiTAIC: hierarchical tumor artificial intelligence classifier traces tissue of origin and tumor type in primary and metastasized tumors using DNA methylation

Author:

Zhang Ze12ORCID,Lu Yunrui2ORCID,Vosoughi Soroush3ORCID,Levy Joshua J124ORCID,Christensen Brock C125ORCID,Salas Lucas A125ORCID

Affiliation:

1. Department of Epidemiology, Geisel School of Medicine at Dartmouth , Lebanon , NH, USA

2. Quantitative Biomedical Sciences Program, Guarini School of Graduate and Advanced Studies , Dartmouth College, Hanover , NH, USA

3. Department of Computer Science , Dartmouth College, Hanover , NH, USA

4. Department of Pathology and Dermatology, Geisel School of Medicine at Dartmouth , Lebanon , NH, USA

5. Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth , Lebanon , NH, USA

Abstract

Abstract Human cancers are heterogenous by their cell composition and origination site. Cancer metastasis generates the conundrum of the unknown origin of migrated tumor cells. Tracing tissue of origin and tumor type in primary and metastasized cancer is vital for clinical significance. DNA methylation alterations play a crucial role in carcinogenesis and mark cell fate differentiation, thus can be used to trace tumor tissue of origin. In this study, we employed a novel tumor-type-specific hierarchical model using genome-scale DNA methylation data to develop a multilayer perceptron model, HiTAIC, to trace tissue of origin and tumor type in 27 cancers from 23 tissue sites in data from 7735 tumors with high resolution, accuracy, and specificity. In tracing primary cancer origin, HiTAIC accuracy was 99% in the test set and 93% in the external validation data set. Metastatic cancers were identified with a 96% accuracy in the external data set. HiTAIC is a user-friendly web-based application through https://sites.dartmouth.edu/salaslabhitaic/. In conclusion, we developed HiTAIC, a DNA methylation-based algorithm, to trace tumor tissue of origin in primary and metastasized cancers. The high accuracy and resolution of tumor tracing using HiTAIC holds promise for clinical assistance in identifying cancer of unknown origin.

Funder

Department of Defense

National Institute of General Medical Sciences

National Cancer Institute

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Reference60 articles.

1. Cancer statistics, 2022;Siegel;CA Cancer J. Clin.,2022

2. Cancer metastases: challenges and opportunities;Guan;Acta Pharm. Sin. B,2015

3. Molecular principles of metastasis: a hallmark of cancer revisited;Fares;Signal Transduct. Target. Ther.,2020

4. Metastatic cancer of unknown primary” or “primary Metastatic cancer”?;Kolling;Front. Oncol.,2019

5. Cancer of unknown primary: a review on clinical guidelines in the development and targeted management of patients with the unknown primary site;Qaseem;Cureus,2019

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3